| |
| |
|
| Insider
Information: |
Martin John C |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,895,138 |
|
|
Indirect Shares
|
2,684,281 |
|
|
| Direct
Value |
$190,177,921 |
|
|
|
Indirect Value
|
$47,947,883 |
|
|
| Total
Shares |
5,579,419 |
|
|
| Total
Value |
$238,125,804 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,726 |
7,913 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2020-10-14 |
4 |
B |
$19.00 |
$1,440,200 |
I/I |
75,800 |
1,952,364 |
2.1 |
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$3,314,949 |
I/I |
1,876,564 |
1,876,564 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,187 |
5,187 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-02-06 |
4 |
D |
$68.75 |
$947,856 |
D/D |
(13,787) |
2,887,225 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,250 |
2,901,012 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-12-03 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
2,927,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-12-03 |
4 |
AS |
$70.90 |
$3,560,178 |
D/D |
(50,000) |
2,877,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
140,000 |
2,877,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-11-01 |
4 |
AS |
$68.61 |
$3,477,617 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-11-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-10-01 |
4 |
AS |
$77.90 |
$3,902,210 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-10-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-09-04 |
4 |
AS |
$74.11 |
$3,708,034 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-09-04 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-08-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-08-01 |
4 |
AS |
$77.85 |
$3,892,650 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-07-02 |
4 |
AS |
$70.80 |
$3,540,282 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-07-02 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-06-01 |
4 |
AS |
$68.13 |
$3,406,495 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-06-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-05-01 |
4 |
AS |
$72.19 |
$3,609,660 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-05-01 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-04-02 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,067,762 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-04-02 |
4 |
AS |
$72.51 |
$3,656,806 |
D/D |
(50,000) |
3,017,762 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
